Ocugen (OCGN) Cash & Equivalents Growth (3y) (2017 - 2025)
Ocugen (OCGN) Cash & Equivalents Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
24.73% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
21.66% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
-33.71% |
| Jun 30, 2024 |
-48.61% |
| Mar 31, 2024 |
-16.16% |
| Dec 31, 2023 |
17.97% |
| Sep 30, 2023 |
40.93% |
| Jun 30, 2023 |
67.69% |
| Mar 31, 2023 |
177.54% |
| Dec 31, 2022 |
118.41% |
| Sep 30, 2022 |
87.96% |
| Jun 30, 2022 |
453.42% |
| Mar 31, 2022 |
649.10% |
| Dec 31, 2021 |
287.81% |
| Sep 30, 2021 |
250.94% |
| Jun 30, 2021 |
136.23% |
| Mar 31, 2021 |
42.42% |
| Dec 31, 2020 |
50.29% |
| Sep 30, 2020 |
20.95% |
| Jun 30, 2020 |
12.32% |
| Mar 31, 2020 |
-42.01% |
| Dec 31, 2019 |
-38.44% |
